USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
NYSE:USNA • US90328M1071
20.09 USD
-1.43 (-6.64%)
At close: Mar 2, 2026
20.09 USD
0 (0%)
After Hours: 3/2/2026, 8:04:00 PM
Taking everything into account, USNA scores 6 out of 10 in our fundamental rating. USNA was compared to 37 industry peers in the Personal Care Products industry. While USNA has a great health rating, its profitability is only average at the moment. USNA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year USNA was profitable.
- In the past year USNA had a positive cash flow from operations.
- USNA had positive earnings in each of the past 5 years.
- Of the past 5 years USNA 4 years had a positive operating cash flow.
1.2 Ratios
- USNA has a Return On Assets of 2.34%. This is comparable to the rest of the industry: USNA outperforms 56.76% of its industry peers.
- USNA has a Return On Equity of 3.22%. This is in the better half of the industry: USNA outperforms 64.86% of its industry peers.
- USNA's Return On Invested Capital of 5.43% is fine compared to the rest of the industry. USNA outperforms 62.16% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.10%.
- The last Return On Invested Capital (5.43%) for USNA is well below the 3 year average (9.82%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROIC | 5.43% |
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
1.3 Margins
- USNA has a Profit Margin (1.86%) which is comparable to the rest of the industry.
- USNA's Profit Margin has declined in the last couple of years.
- USNA has a Operating Margin of 4.58%. This is comparable to the rest of the industry: USNA outperforms 56.76% of its industry peers.
- In the last couple of years the Operating Margin of USNA has declined.
- The Gross Margin of USNA (79.18%) is better than 94.59% of its industry peers.
- USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% |
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
- The number of shares outstanding for USNA has been reduced compared to 1 year ago.
- Compared to 5 years ago, USNA has less shares outstanding
- The debt/assets ratio for USNA has been reduced compared to a year ago.
2.2 Solvency
- USNA has an Altman-Z score of 3.78. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
- USNA's Altman-Z score of 3.78 is fine compared to the rest of the industry. USNA outperforms 78.38% of its industry peers.
- There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.78 |
ROIC/WACC0.65
WACC8.36%
2.3 Liquidity
- A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
- USNA's Current ratio of 2.23 is in line compared to the rest of the industry. USNA outperforms 59.46% of its industry peers.
- A Quick Ratio of 1.46 indicates that USNA should not have too much problems paying its short term obligations.
- USNA has a Quick ratio (1.46) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 |
3. Growth
3.1 Past
- USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.15%.
- The earnings per share for USNA have been decreasing by -20.00% on average. This is quite bad
- Looking at the last year, USNA shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
- Measured over the past years, USNA shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
3.2 Future
- USNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.18% yearly.
- Based on estimates for the next years, USNA will show a small growth in Revenue. The Revenue will grow by 4.74% on average per year.
EPS Next Y3.59%
EPS Next 2Y22.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.37%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 10.46, the valuation of USNA can be described as very reasonable.
- 81.08% of the companies in the same industry are more expensive than USNA, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.13, USNA is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 10.10, the valuation of USNA can be described as reasonable.
- USNA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. USNA is cheaper than 78.38% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, USNA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.46 | ||
| Fwd PE | 10.1 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 97.30% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.87 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- USNA has a very decent profitability rating, which may justify a higher PE ratio.
- USNA's earnings are expected to grow with 22.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.91
PEG (5Y)N/A
EPS Next 2Y22.18%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
20.09
-1.43 (-6.64%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17 2026-02-17/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners61.98%
Inst Owner Change0.29%
Ins Owners0.6%
Ins Owner Change0.33%
Market Cap367.25M
Revenue(TTM)925.26M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (98.01%)
Short Float %4.62%
Short Ratio3.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.46 | ||
| Fwd PE | 10.1 | ||
| P/S | 0.4 | ||
| P/FCF | N/A | ||
| P/OCF | 11.65 | ||
| P/B | 0.7 | ||
| P/tB | 1.5 | ||
| EV/EBITDA | 3.87 |
EPS(TTM)1.92
EY9.56%
EPS(NY)1.99
Fwd EY9.9%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY8.58%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)2.91
PEG (5Y)N/A
Graham Number35.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROCE | 6.88% | ||
| ROIC | 5.43% | ||
| ROICexc | 7.14% | ||
| ROICexgc | 18.34% | ||
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% | ||
| FCFM | N/A |
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 973.94% | ||
| Cap/Sales | 23.69% | ||
| Interest Coverage | 62.89 | ||
| Cash Conversion | 49.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.78 |
F-Score7
WACC8.36%
ROIC/WACC0.65
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y3.59%
EPS Next 2Y22.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year3.37%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year32.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-381.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.2%
OCF growth 3YN/A
OCF growth 5YN/A
USANA HEALTH SCIENCES INC / USNA FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 6 / 10 to USNA.
Can you provide the valuation status for USANA HEALTH SCIENCES INC?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
Can you provide the profitability details for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.
What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?
The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 8 / 10.
Can you provide the expected EPS growth for USNA stock?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 3.59% in the next year.